(-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine

European Journal of Pharmacology

Volumn 303, Issue 3, 1996, Pages 183-186

  Hjorth, Stephan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

( ) pindolol; 5 HT (5 hydroxytryptamine, serotonin), extracellular; 5 HT(1A) autoreceptor antagonism; buspirone; citalopram; microdialysis, in vivo; selective serotonin reuptake inhibitor (SSRI)

Indexed keywords

AUTORECEPTOR; BUSPIRONE; CITALOPRAM; PINDOLOL; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; HIPPOCAMPUS; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAPHE NUCLEUS; RAT; SEROTONIN RELEASE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029904312     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00185-9     Document Type: Article

References (16)

1. Artigas, F., 1993, 5-HT and antidepressants - new views from microdialysis studies, Trends Pharmacol. Sci. 14, 262.
2. Artigas, F., V. Perez and E. Alvarez, 1994, Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors, Arch. Gen. Psychiatry 51, 248.
3. Blier, P. and R. Bergeron, 1995, Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression, J. Clin. Psychopharmacol. 15, 217.
4. Bohmaker, K., A.S. Eison, F.D. Yocca and E. Meller, 1993, Comparative effects of chronic 8-OH-DPAT, gepirone and ipsapirone treatment on the sensitivity of somatodendritic 5-HT1A autoreceptors, Neuropharmacology 32, 527.
5. 1A agonists, Synapse 14, 297.
6. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo - a microdialysis study, J. Neurochem. 60, 776.
7. 1A autoreceptors in the effect of 5-HT reuptake blockade on extracellular 5-HT levels in the rat brain, Soc. Neurosci. Abstr. 21, 1368.
8. 1B autoreceptor blocking properties of the β-adrenoceptor antagonist (-)penbutolol, J. Pharmacol. Exp. Ther. 265, 707.
9. 1A antagonists, WAY100635 and (-)pindolol, augment the 5-HT-elevating effect of the SSRI citalopram in vivo, whereas buspirone does not; systemic and intra-raphe drug injection studies. Psychopharmacology (Suppl.), in press.
10. 1 recognition sites, J. Receptor Res. 8, 59.
11. Invernizzi, R., S. Belli and R. Samanin, 1992, Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex, Brain Res. 584, 322.
12. Jacobsen, F.M., 1991, Possible augmentation of antidepressant response by buspirone, J. Clin. Psychiatry 52, 217.
13. Joffe, R.T. and D.R. Schuller, 1993, An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression, J. Clin. Psychiatry 54, 269.
14. Middlemiss, D.N., J. Neill and M.D. Tricklebank, 1985, Subtypes of the 5-HT receptor involved in hypothermia and forepaw treading induced by 8-OH-DPAT, Br. J. Pharmacol. 85, 251P.
15. Paxinos, G. and C. Watson, 1986, The Rat Brain in Stereotaxic Coordinates, 2nd edn. (Academic Press, San Diego, CA).
16. 1A receptor antagonist WAY100135 - an in vivo microdialysis study, Eur. J. Pharmacol. 239, 195.